Functional decline over time in patients with IPF treated with pirfenidone: the PROOF registry

W. Wuyts (Leuven, Belgium), C. Dahlqvist (Yvoir, Belgium), H. Slabbynck (Antwerp, Belgium), M. Schlesser (Luxembourg City, Luxembourg), N. Gusbin (Liège, Belgium), C. Compere (Brussels, Belgium), S. Maddens (Kortrijk, Belgium), K. Kirchgaessler (Basel, Switzerland), K. Bartley (South San Francisco, CA, United States of America), B. Bondue (Brussels, Belgium)

Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries
Session: The world of idiopathic pulmonary fibrosis (IPF): global registries
Session type: Poster Discussion
Number: 2201
Disease area: Interstitial lung diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
W. Wuyts (Leuven, Belgium), C. Dahlqvist (Yvoir, Belgium), H. Slabbynck (Antwerp, Belgium), M. Schlesser (Luxembourg City, Luxembourg), N. Gusbin (Liège, Belgium), C. Compere (Brussels, Belgium), S. Maddens (Kortrijk, Belgium), K. Kirchgaessler (Basel, Switzerland), K. Bartley (South San Francisco, CA, United States of America), B. Bondue (Brussels, Belgium). Functional decline over time in patients with IPF treated with pirfenidone: the PROOF registry. 2201

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: